St. Bortolo Hospital Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2009
NCT00992134
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (3)

bendamustine (treanda) (1 trial)

cytarabine (cytosar-u) (1 trial)

rituximab (rituxan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lymphoma (Phase 2)

Lymphoma, Mantle-Cell (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 3